News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,445 Results
Type
Article (41650)
Company Profile (252)
Press Release (663543)
Section
Business (206376)
Career Advice (2095)
Deals (35678)
Drug Delivery (109)
Drug Development (82122)
Employer Resources (173)
FDA (16425)
Job Trends (15123)
News (349454)
Policy (33497)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2624)
Accelerated approval (2)
Adcomms (22)
Allergies (82)
Alliances (50118)
ALS (86)
Alzheimer's disease (1380)
Antibody-drug conjugate (ADC) (117)
Approvals (16417)
Artificial intelligence (231)
Autoimmune disease (15)
Automation (14)
Bankruptcy (366)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (178)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (250)
Cancer (2003)
Cardiovascular disease (157)
Career advice (1748)
Career pathing (31)
CAR-T (143)
Cell therapy (401)
Cervical cancer (18)
Clinical research (66434)
Collaboration (780)
Compensation (446)
Complete response letters (20)
COVID-19 (2644)
CRISPR (37)
C-suite (203)
Cystic fibrosis (100)
Data (1909)
Decentralized trials (2)
Denatured (18)
Depression (40)
Diabetes (260)
Diagnostics (6385)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (109)
Drug shortages (30)
Duchenne muscular dystrophy (87)
Earnings (86751)
Editorial (34)
Employer branding (22)
Employer resources (147)
Events (112909)
Executive appointments (630)
FDA (17528)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (692)
Gene editing (99)
Generative AI (20)
Gene therapy (286)
GLP-1 (771)
Government (4722)
Grass and pollen (4)
Guidances (48)
Healthcare (19150)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2781)
Inflammatory bowel disease (135)
Inflation Reduction Act (9)
Influenza (47)
Intellectual property (83)
Interviews (336)
IPO (16567)
IRA (42)
Job creations (3781)
Job search strategy (1481)
Kidney cancer (9)
Labor market (34)
Layoffs (469)
Leadership (18)
Legal (8089)
Liver cancer (72)
Lung cancer (294)
Lymphoma (130)
Machine learning (2)
Management (58)
Manufacturing (277)
MASH (63)
Medical device (13509)
Medtech (13514)
Mergers & acquisitions (19568)
Metabolic disorders (694)
Multiple sclerosis (71)
NASH (22)
Neurodegenerative disease (83)
Neuropsychiatric disorders (27)
Neuroscience (1862)
NextGen: Class of 2025 (6638)
Non-profit (4586)
Northern California (2392)
Now hiring (38)
Obesity (384)
Opinion (221)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (76)
Parkinson's disease (134)
Partnered (18)
Patents (202)
Patient recruitment (93)
Peanut (48)
People (57653)
Pharmaceutical (64)
Pharmacy benefit managers (20)
Phase I (20650)
Phase II (29212)
Phase III (21877)
Pipeline (976)
Podcasts (68)
Policy (114)
Postmarket research (2617)
Preclinical (8761)
Press Release (67)
Prostate cancer (92)
Psychedelics (33)
Radiopharmaceuticals (245)
Rare diseases (363)
Real estate (5972)
Recruiting (66)
Regulatory (22656)
Reports (46)
Research institute (2367)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (2)
RSV (41)
Schizophrenia (65)
Series A (121)
Series B (77)
Service/supplier (12)
Sickle cell disease (53)
Southern California (2068)
Special edition (16)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3624)
State (2)
Stomach cancer (14)
Supply chain (63)
The Weekly (47)
United States (20974)
Vaccines (683)
Venture capitalists (37)
Webinars (12)
Weight loss (280)
Women's health (35)
Worklife (15)
Date
Today (28)
Last 7 days (569)
Last 30 days (2635)
Last 365 days (33880)
2025 (7730)
2024 (35613)
2023 (40444)
2022 (51622)
2021 (56260)
2020 (54757)
2019 (47414)
2018 (35723)
2017 (32582)
2016 (32089)
2015 (38127)
2014 (31806)
2013 (26776)
2012 (28973)
2011 (29659)
2010 (27723)
Location
Africa (754)
Alabama (49)
Alaska (7)
Arizona (228)
Arkansas (13)
Asia (38330)
Australia (6335)
California (5462)
Canada (1875)
China (474)
Colorado (244)
Connecticut (258)
Delaware (124)
Europe (82644)
Florida (814)
Georgia (190)
Idaho (59)
Illinois (496)
India (24)
Indiana (294)
Iowa (9)
Japan (140)
Kansas (102)
Kentucky (24)
Louisiana (7)
Maine (60)
Maryland (829)
Massachusetts (4116)
Michigan (209)
Minnesota (370)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (65)
New Jersey (1553)
New Mexico (28)
New York (1568)
North Carolina (917)
North Dakota (8)
Northern California (2392)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1242)
Puerto Rico (9)
Rhode Island (26)
South America (1125)
South Carolina (18)
South Dakota (1)
Southern California (2068)
Tennessee (93)
Texas (812)
Utah (163)
Virginia (130)
Washington D.C. (59)
Washington State (509)
West Virginia (3)
Wisconsin (48)
705,445 Results for "eli lilly canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
March 26, 2025
·
2 min read
Press Releases
Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
February 26, 2025
·
2 min read
Immunology and inflammation
Lilly’s I&I Push Gains Momentum With Omvoh Expansion
Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according to analysts from BMO Capital Markets.
January 16, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Lilly Signs Back-to-Back Deals in MASH, Cancer
Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals and another for cancer therapies with Australia’s AdvanCell.
February 11, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Lilly Makes $780M+ IPF Play with Mediar Partnership
Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early studies have found to be safe and capable of engaging its target.
January 10, 2025
·
2 min read
·
Tristan Manalac
Earnings
Lilly Projects 2024 Revenue Miss as Zepbound, Mounjaro Disappoint
The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, sent Eli Lilly’s shares cratering by as much as 8% Tuesday, even as the company forecasted robust 2025 revenue.
January 14, 2025
·
2 min read
·
Dan Samorodnitsky
Government
Lilly, Pfizer Execs Sing Optimistic Tune on Incoming Admin After Trump Dinner
A week after dining with Trump and his team at Mar-a-Lago, leaders at Pfizer and Eli Lilly have publicly stated that they intend to collaborate with the incoming administration on key issues affecting the pharma industry.
December 12, 2024
·
2 min read
·
Tristan Manalac
GLP-1
Lilly Asks to Join GLP-1 Compounding Lawsuit
Eli Lilly’s request to intervene in a suit filed by compounding pharmacies against the FDA reflects a belief the outcome could affect its business and that the FDA does not adequately represent its interests.
January 3, 2025
·
2 min read
·
Nick Paul Taylor
Editorial
Eli Lilly’s Q3 Miss for Mounjaro, Zepbound Highlights Dependency on Wholesalers
Lilly CEO Dave Ricks in Wednesday’s third-quarter earnings call acknowledged that the company is at the mercy of wholesaler stocking decisions.
November 1, 2024
·
3 min read
·
Greg Slabodkin
Career Pathing
From Eli Lilly to Entrepreneur: A Journey to Independent Consulting
After more than 20 years at Eli Lilly, Leslie Sam moved into independent consulting. To prepare for the transition, she focused on becoming technically deep and earning industry recognition.
July 31, 2024
·
4 min read
·
Angela Gabriel
1 of 70,545
Next
